Anticipation

Kartoon Studios Reports Strong Progress and Provides Business Update for the Fourth Quarter and Full Year of 2023

Retrieved on: 
Tuesday, April 9, 2024
Universe, Child, Moonbug Entertainment, SuperKitties, The Walt Disney Company, Cost, Cartoon, Marketing, NFL, Spin Master, Canadian Tire money, Business, Disney Branded Television, Warner Bros., Anticipation, SAG, Catalog, Organization, Screen Actors Guild, Animation, Cocomelon, Acquisition, AI, Security (finance), PBS Kids, Q3, WGA, Genius Brands, Writers Guild, Growth, Apple, CFO, Actor, Traction, Fruit, Generate, Video game

Andy Heyward, Chairman & CEO of Kartoon Studios, stated, “2023 was a transformative year for the Company as we laid the foundation for long-term growth and sustainable profitability.

Key Points: 
  • Andy Heyward, Chairman & CEO of Kartoon Studios, stated, “2023 was a transformative year for the Company as we laid the foundation for long-term growth and sustainable profitability.
  • At the same time, Kartoon Channel!’s paid subscriber base continues to grow, providing us with high margin recurring revenue.
  • Moreover, our Beacon Media Group subsidiary has resumed solid growth and, in Q4 2023, achieved its highest quarter revenue since 2021.
  • The team of players now inside Kartoon Studios brings extraordinary playing records at Disney, Warner Brothers, Hasbro, and other leading organizations.

Empire Petroleum Announces Results for Fourth Quarter and Full Year 2023

Retrieved on: 
Monday, April 1, 2024
Oil, Gas, Energy, Permian, Natural gas, Growth, G&A, AGU, LOE, NGL, Atlas, DD, Anticipation, Consultant, Economics

Empire Petroleum (NYSE American: EP) (“Empire” or the “Company”), an oil and gas company with producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana today announced operational and financial results for the fourth quarter and full year of 2023, including year-end 2023 proved reserves.

Key Points: 
  • Empire Petroleum (NYSE American: EP) (“Empire” or the “Company”), an oil and gas company with producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana today announced operational and financial results for the fourth quarter and full year of 2023, including year-end 2023 proved reserves.
  • Mike Morrisett, President and Chief Executive Officer of Empire, commented, “We are committed to executing on our targeted plan for developing our unique asset base.
  • We see significant potential given our top-notch group of technical professionals led by the oversight of Phil Mulacek.
  • Bottom line, we are looking at 2024 to be a real turning point for Empire.

AdvanSix Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Friday, February 16, 2024
Other Manufacturing, Textiles, Packaging, Other Energy, Chemicals, Plastics, Manufacturing, Energy, Agriculture, Natural Resources, Anticipation, Capital expenditure, Risk, AdvanSix, Capital, Nitrogen, Environment, Ammonium sulfate, Risk management

Capital expenditures of $38.4 million in the quarter increased $9.9 million versus the prior year primarily reflecting increased spend on enterprise programs and other maintenance projects.

Key Points: 
  • Capital expenditures of $38.4 million in the quarter increased $9.9 million versus the prior year primarily reflecting increased spend on enterprise programs and other maintenance projects.
  • We thank our customers, partners and AdvanSix teammates for their collaboration and agility to mitigate the value chain impact of this event.
  • AdvanSix will discuss its results during its investor conference call today starting at 9:00 a.m.
  • ET start, and tell the operator that you are dialing in for AdvanSix’s fourth quarter 2023 earnings call.

Ring Energy Announces Production Results and Continued Debt Reduction for Fourth Quarter 2023 and Partial Guidance for the First Quarter 2024

Retrieved on: 
Monday, January 29, 2024
Weather, Anticipation, REI, Acquisition, Cryptocurrency

THE WOODLANDS, Texas, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an operational and financial update for the fourth quarter of 2023, as well as production and capital spending guidance for the first quarter of 2024.

Key Points: 
  • THE WOODLANDS, Texas, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an operational and financial update for the fourth quarter of 2023, as well as production and capital spending guidance for the first quarter of 2024.
  • The result was an outstanding fourth quarter and we look forward to reporting our full results in early March.
  • We began 2024 with a phased, two-rig drilling program, targeting our highest rate-of-return horizontal and vertical drilling inventory.
  • We appreciate the support of our stockholders and look forward to a successful 2024.”

Tonkean Intake Orchestration Now Available on SAP® Store

Retrieved on: 
Tuesday, January 9, 2024
ERP, SAP, Anticipation, SAP ERP, PALO, ISBN, CRM, SAP Ariba, Maple syrup

PALO ALTO, Calif., Jan. 9, 2024 /PRNewswire/ -- Tonkean Inc., the provider of AI-powered process orchestration for enterprises, today announced that Tonkean Intake Orchestration is now available on SAP® Store. Tonkean Intake Orchestration integrates with SAP Ariba Catalog, SAP Ariba Buying and Invoicing, and SAP ERP, private cloud edition. It helps internal teams build and orchestrate AI-enhanced guided intake experiences that serve to increase process adoption, maximize efficiency, and increase spend under management in SAP Ariba solutions.

Key Points: 
  • By integrating with SAP Ariba solutions, Tonkean Intake Orchestration delivers a holistic AI-powered intake management solution to ISBN clients.
  • PALO ALTO, Calif., Jan. 9, 2024 /PRNewswire/ -- Tonkean Inc., the provider of AI-powered process orchestration for enterprises, today announced that Tonkean Intake Orchestration is now available on SAP® Store .
  • Tonkean Intake Orchestration integrates with SAP Ariba Catalog, SAP Ariba Buying and Invoicing, and SAP ERP, private cloud edition.
  • Tonkean Intake Orchestration empowers customers in a number of ways:
    Drive greater adoption with a frictionless intake experience.

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023
Renal cell carcinoma, Trae Elston, Anticipation, Liver disease, Research, Annual general meeting, Safety, Research and development, Therapy, Completeness, Colorectal cancer, Hypertelorism, CRC, Liver, PD, FC, ESMO, Administration, Patient, MSS, Tumor microenvironment, Immunotherapy, G&A, RCC, DCR, TME, Melanoma, Cancer, SITC, Roche, R, Oncology, Phase II, Neoplasm, Society, Cell, Pharming, Biopsy, Medical imaging, Pharmaceutical industry, Vaccine, Cryptocurrency

WALTHAM, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Xilio anticipates activating clinical trial sites for the Phase 1 combination dose escalation in the fourth quarter of 2023.
  • As previously announced, Xilio anticipates reporting preliminary safety data from the Phase 1 clinical trial into the third dose level in the fourth quarter of 2023.
  • General & Administrative (G&A) Expenses: G&A expenses were $6.3 million for the quarter ended September 30, 2023, compared to $7.2 million for the quarter ended September 30, 2022.
  • Net Loss: Net loss was $16.7 million for the quarter ended September 30, 2023, compared to $19.8 million for the quarter ended September 30, 2022.

Anticipate Outstanding Deals at Red Apple & The Bargain! Shop During Black Friday & Cyber Monday

Retrieved on: 
Monday, November 20, 2023
Electronics, Anticipation, Red apple, Cyber Monday, Black Friday, Metropolitan Stores, Nightclub

MISSISSAUGA, ON, Nov. 20, 2023 /CNW/ - Exciting discounts await shoppers as Red Apple Stores and The Bargain!

Key Points: 
  • MISSISSAUGA, ON, Nov. 20, 2023 /CNW/ - Exciting discounts await shoppers as Red Apple Stores and The Bargain!
  • Shop gear up for their highly anticipated Black Friday and Cyber Monday sales events.
  • Anticipate Outstanding Deals at Red Apple & The Bargain!
  • Shop During Black Friday & Cyber Monday.

Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update

Retrieved on: 
Wednesday, November 8, 2023
FDA, Research, Yoy, PDUFA, Catalysis, Intangibles, Anticipation, GAAP, Acquisition, Orange Book, Development, Vamorolone, Bank statement, PMDA, Growth, Amifampridine, COVID-19, Duchenne muscular dystrophy, Webcast, Intangible asset, Lambert–Eaton myasthenic syndrome, IPR, NDA, Epilepsy, Accounting, Administration, Cash, YTD, Bank, Pharmaceutical industry, Beauty salon, Video game, Cryptocurrency

These non-GAAP financial measures are intended to enhance an overall understanding of Catalyst's current financial performance.

Key Points: 
  • These non-GAAP financial measures are intended to enhance an overall understanding of Catalyst's current financial performance.
  • Non-GAAP financial measures should not be considered in isolation or as a substitute for comparable GAAP accounting.
  • Intangible assets acquired after the third quarter of 2022 relate to the FYCOMPA rights acquired in the first quarter of 2023.
  • The Company will host a conference call and webcast on Thursday, November 9, 2023, at 8:30 AM ET to discuss the financial results and provide a business update.

AdvanSix Announces Third Quarter 2023 Financial Results

Retrieved on: 
Friday, November 3, 2023
Other Manufacturing, Textiles, Packaging, Other Energy, Chemicals, Plastics, Manufacturing, Energy, Agriculture, Natural Resources, EBITDA, AAO, Anticipation, Maintenance, AdvanSix, Carlisle Companies, Ammonium sulfate, Growth, MEKO, Capital expenditure, Investment, Oben, Capital, Life insurance

Capital expenditures of $25.1 million in the quarter increased $2.9 million versus the prior year.

Key Points: 
  • Capital expenditures of $25.1 million in the quarter increased $2.9 million versus the prior year.
  • The dividend is payable on November 28, 2023 to stockholders of record as of the close of business on November 14, 2023.
  • AdvanSix will discuss its results during its investor conference call today starting at 9:00 a.m.
  • ET start, and tell the operator that you are dialing in for AdvanSix’s third quarter 2023 earnings call.

MindMed Reports Third Quarter 2023 Financial Results and Business Highlights

Retrieved on: 
Thursday, November 2, 2023
Biotechnology, Neurology, Other Health, Health, Clinical Trials, Week, Spectrum, AISRS, Congress, Prevalence, G&A, Telephone, Finance, University Hospital of Basel, Volunteering, Research, Pharmacokinetics, Growth, Attention deficit hyperactivity disorder predominantly inattentive, Clinical trial, Medicine, ECNP, Webcast, Research and development, Anticipation, European College of Neuropsychopharmacology, USD, GAD, NEO, UHB, ASD, MindMed, Patient, Administration, ADHD, Pharmaceutical industry, Birth control, Dietary supplement, Vaccine, Cryptocurrency, R

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its financial results for the quarter ended September 30, 2023.

Key Points: 
  • Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its financial results for the quarter ended September 30, 2023.
  • Dosing is complete with topline results for the primary endpoint (Week 4) expected to be announced in Q4 2023.
  • R&D expenses were $13.2 million for the quarter ended September 30, 2023, compared to $7.8 million for the quarter ended September 30, 2022, an increase of $5.4 million.
  • MindMed management will host a conference call at 4:30 PM EST today to provide a corporate update and review the Company’s third quarter 2023 financial results.